News Abbott Laboratories Swiss Exchange

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Delayed Swiss Exchange Other stock markets 11:35:28 2026-07-24 am EDT			5-day change	1st Jan Change
84.50 ^CHF	+2.42%		+4.32%	-14.65%

Jul. 24	Abbott defeats shareholder lawsuit over 2022 infant formula recall	RE
Jul. 24	Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall	RE

All News

Mentions Relevance

Jul. 24	Abbott defeats shareholder lawsuit over 2022 infant formula recall	RE
Jul. 24	Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall	RE
Jul. 23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
Jul. 22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
Jul. 17	Abbott investigates two separate cyber incidents, says no operations affected	RE
Jul. 17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
Jul. 17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
Jul. 17	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
Jul. 17	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
Jul. 17	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
Jul. 17	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
Jul. 17	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
Jul. 16	Army integrating new handheld device to quickly assess brain injuries	AQ
Jul. 16	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
Jul. 16	Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise	MT
Jul. 16	Abbott Laboratories Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
Jul. 16	Abbott Laboratories, Q2 2026 Earnings Call, Jul 16, 2026
Jul. 16	Abbott Laboratories Raises Full-Year Earnings Guidance as Second-Quarter Results Top Views	MT
Jul. 16	Abbott Laboratories : ABT 2026 Q2 Exhibit 99.1 FINAL	PU
Jul. 16	Abbott Laboratories 2Q Sales Rise on Diagnostics Growth	DJ
Jul. 16	Abbott raises its 2026 adjusted EPS target range
Jul. 16	Abbott Laboratories Q2 Adjusted Earnings, Revenue Rise; Raises 2026 Earnings Guidance	MT
Jul. 16	Abbott: Q2 Earnings Snapshot	AQ
Jul. 16	(ABT) Abbott Laboratories Expects Q3 Adjusted EPS Range $1.38 - $1.46	MT
Jul. 16	(ABT) Abbott Laboratories Expects 2026 Adjusted EPS Range $5.45 to $5.60, vs. FactSet Est of $5.47	MT